We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

Open Position

New PhD opportunities at HPC: Helmholtz International Epigenetics Research School

© Helmholtz Zentrum München/Carolin Jacklin

The Helmholtz Pioneer Campus will be part of the Helmholtz International Epigenetics Research School, an international and interdisciplinary graduate program centered on epigenetics research at Helmholtz Zentrum München, in Munich, Germany.

 

The Helmholtz International Epigenetics Research School provides an optimal research and training environment for graduate students to conduct their PhD research in the field of epigenetics and HPC principal investigator Dr. Celia P Martinez-Jimenez will be participating in the training program with a project focused on epigenetic and ageing.

 

Find out more about Celia P-Martinez-Jimenez project and apply now.

Project title 
Epigenetic signatures of ageing and chronic disease.

Co-supervision 
Dr. Celia P Martinez-Jimenez (HPC) and Dr. Maria Colome-Tatche (ICB)

Project summary 
From epidemiological studies and experimental data, we know that chronic diseases accelerate the ageing process, suggesting that ageing and chronic diseases share common mechanisms. In human and mouse models, ageing is generally associated with a physiological increase in lipid accumulation in non-adipose tissues including the liver. This aged phenotype in liver closely mirrors the main features of the most common chronic disease in liver, non-alcoholic fatty liver disease (NAFLD). Chronic liver diseases affect the metabolic function of the liver and non-alcoholic fatty liver has been identified as a potential cause of drug-induced liver injury in elderly. We will use mouse models for NAFLD as well as human samples (from biobanks) to investigate the effect of chronic accumulation of lipids in the liver at the single-cell level. We will focus on single-cell DNA methylation, scATAC-seq and scRNA-seq and the development of a computational approach to integrate and harmonize those datasets. The goal is to map the epigenetic features that correlates with changes in the hepatic transcriptional network in NAFLD and ageing, and use those epigenetic signatures as predictive marks of accelerated ageing.